McGuire Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
McGuire Capital Advisors's VRTX Position: Q2 2026 in Review
McGuire Capital Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 78% in Q2 2026, selling an estimated $7.98K and leaving 5 shares worth $2.48K. The position accounts for ﹤0.01% of the portfolio, ranked #673.
McGuire Capital Advisors first reported a position in VRTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $10.3K in Q1 2026. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- McGuire Capital Advisors held 5 shares of Vertex Pharmaceuticals worth $2.48K as of Q2 2026.
- McGuire Capital Advisors sold 18 Vertex Pharmaceuticals shares in Q2 2026, an estimated $7.98K.
- Vertex Pharmaceuticals made up ﹤0.01% of McGuire Capital Advisors's portfolio in Q2 2026, its #673 holding.
- McGuire Capital Advisors first reported a position in Vertex Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- McGuire Capital Advisors's Vertex Pharmaceuticals position peaked at $10.3K in Q1 2026.
- 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.